Valinomycin-stimulated glycolysis in Ehrlich ascites tumor cells.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001693:Biological Transport, Active; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D002586:Cesium / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D008566:Membranes / Q000378:metabolism; D051379:Mice; D008928:Mitochondria / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010101:Oxygen Consumption; D011123:Polyploidy; D011188:Potassium / Q000378:metabolism*; D012413:Rubidium / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002586:Cesium; D010042:Ouabain; D000251:Adenosine Triphosphatases; D012413:Rubidium; D011188:Potassium